Bill Lundberg, Merus CEO
#ASCO24: Merus, touting more Phase 2 data, plots pivotal head and neck cancer trial in first-line setting
Merus released additional head and neck cancer data from a Phase 2 study on Tuesday after publishing an ASCO abstract last week and outlined plans …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
